Mark Kester Selected Research

Mark Kester Research Topics

Disease

66	Neoplasms (Cancer) 02/2024 - 10/2004
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 09/2014
14	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2003
13	Leukemia 03/2023 - 08/2010
10	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017 - 07/2009
6	Neoplasm Metastasis (Metastasis) 01/2016 - 05/2009
5	Inflammation (Inflammations) 11/2023 - 06/2008
5	Melanoma (Melanoma, Malignant) 01/2022 - 10/2004
5	Adenocarcinoma 10/2017 - 11/2003
4	Infections 01/2020 - 01/2007
4	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 04/2013
4	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2012 - 09/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2013
3	Carcinogenesis 01/2023 - 05/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 05/2011
2	Triple Negative Breast Neoplasms 02/2024 - 11/2012
2	Hyperplasia 11/2023 - 04/2007
2	Disease Progression 09/2021 - 01/2011
2	Obesity 11/2020 - 06/2014
2	Hyperglycemia 10/2012 - 01/2010
2	Neuroblastoma 06/2012 - 12/2010
2	Insulin Resistance 03/2011 - 12/2006
1	Asthma (Bronchial Asthma) 11/2023
1	Fibrosis (Cirrhosis) 11/2023
1	Airway Remodeling 11/2023
1	Cachexia 07/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Squamous Cell Carcinoma of Head and Neck 12/2020

Drug/Important Bio-Agent (IBA)

45	CeramidesIBA 02/2024 - 02/2002
32	SphingolipidsIBA 01/2022 - 12/2002
15	N-caproylsphingosineIBA 01/2022 - 05/2005
13	LipidsIBA 11/2020 - 04/2007
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2004
7	Tamoxifen FDA LinkGeneric 01/2019 - 08/2010
6	Liposomes (Liposome)IBA 11/2023 - 05/2005
6	Small Interfering RNA (siRNA)IBA 01/2017 - 10/2004
5	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2023 - 12/2002
5	EnzymesIBA 01/2020 - 09/2008
5	Glucosylceramides (Glucocerebrosides)IBA 01/2020 - 12/2006
4	Phosphotransferases (Kinase)IBA 01/2020 - 06/2008
4	CalciumIBA 10/2017 - 03/2010
4	sphingosine kinaseIBA 07/2017 - 12/2002
3	Therapeutic UsesIBA 02/2024 - 01/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 05/2016
3	SphingomyelinsIBA 01/2019 - 12/2002
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 08/2010
3	Cholecystokinin B ReceptorIBA 02/2017 - 03/2010
3	Biomarkers (Surrogate Marker)IBA 10/2014 - 01/2011
3	calcium phosphateIBA 12/2008 - 10/2008
2	Messenger RNA (mRNA)IBA 02/2024 - 07/2009
2	Indicators and Reagents (Reagents)IBA 11/2023 - 01/2018
2	CytokinesIBA 11/2023 - 07/2013
2	Epidermal Growth Factor (EGF)IBA 11/2023 - 07/2013
2	venetoclaxIBA 01/2023 - 10/2022
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2022 - 07/2009
2	ceramide glucosyltransferaseIBA 01/2020 - 06/2013
2	GlycosphingolipidsIBA 01/2019 - 12/2006
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2019 - 01/2013
2	AntibodiesIBA 01/2019 - 01/2017
2	Acid CeramidaseIBA 01/2019 - 07/2015
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019 - 11/2012
2	N'- ((1E)- 1- (3,4- dimethoxyphenyl)ethylidene)- 3- (4- methoxyphenyl)- 1H- pyrazole- 5- carbohydrazideIBA 07/2017 - 03/2015
2	Sunitinib (Sutent)FDA Link 01/2017 - 01/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 01/2012
2	Ether (Diethyl Ether)IBA 05/2016 - 07/2010
2	ceramide kinaseIBA 02/2016 - 06/2012
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2013
2	Photosensitizing Agents (Photosensitizers)IBA 03/2013 - 07/2011
2	Streptozocin (Streptozotocin)FDA Link 10/2012 - 03/2011
2	Retinaldehyde (Retinal)IBA 10/2012 - 12/2006
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2012 - 07/2011
2	LigandsIBA 09/2011 - 05/2009
2	NeurotensinIBA 09/2011 - 05/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2011 - 05/2009
2	Potassium Channels (Potassium Channel)IBA 07/2010 - 04/2009
2	ElementsIBA 03/2010 - 10/2008
2	Mitogen-Activated Protein KinasesIBA 09/2008 - 06/2008
1	Aligeron (AS 2)IBA 03/2024
1	OvalbuminIBA 11/2023
1	CaspasesIBA 03/2023
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2023
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2023
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2022
1	VaccinesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	LuciferasesIBA 09/2021
1	Protein Kinases (Protein Kinase)IBA 09/2021
1	AndrogensIBA 12/2020
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	Chloroquine (Aralen)FDA LinkGeneric 12/2020
1	Cadherins (E-Cadherin)IBA 12/2020

Therapy/Procedure

37	Therapeutics 02/2024 - 04/2009
5	Drug Therapy (Chemotherapy) 03/2023 - 02/2015
3	Precision Medicine 01/2018 - 03/2010
3	Photochemotherapy (Photodynamic Therapy) 03/2013 - 07/2011
2	Immunotherapy 01/2022 - 01/2022